US 12110491
Selective reduction of allelic variants
granted A61PA61P25/28
Quick answer
US patent 12110491 (Selective reduction of allelic variants) held by Ionis Pharmaceuticals, Inc. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 50
- CPC classes
- A61P, A61P25/28